Insights into the role of microRNAs in cardiac diseases: From biological signalling to therapeutic targets

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 7, Issue 1, 2009, Pages 82-90

  Zorio, Esther ^a   Medina, P ^a   Rueda, J ^a   Millan J M ^a   Arnau, M A ^a   Beneyto, M ^a   Marin F ^b   Gimeno, J R ^b   Osca, J ^a   Salvador, A ^a   Espana F ^a   Estelles A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Angiogenesis; Cardiac hypertrophy; Connexin; Differentiation; Gene expression; Ion channel; MicroRNA; Repolarization

Indexed keywords

CONNEXIN 43; CYCLIN DEPENDENT KINASE 9; CYCLOOXYGENASE 2; DELAYED RECTIFIER POTASSIUM CHANNEL; DNA POLYMERASE; FIBRONECTIN; HEAT SHOCK PROTEIN; INTERLEUKIN 8; MICRORNA; MYOGENIC FACTOR; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BCL 2; RAS PROTEIN; RHEB PROTEIN; SMALL INTERFERING RNA; THYROID HORMONE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HEART DEVELOPMENT; HEART DISEASE; HEART HYPERTROPHY; HEART MUSCLE; HEART REPOLARIZATION; HUMAN; MUSCLE DEVELOPMENT; NONHUMAN; RNA DEGRADATION; RNA SYNTHESIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE LEVEL; UPREGULATION; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; GENETICS; PHYSIOLOGY; REVIEW;

DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; HEART DISEASES; HUMANS; MICRORNAS;

EID: 64149130392     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152509787047676     Document Type: Article

References (80)

1. Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004, 116, 281.
2. Fitzgerald, K. RNAi versus small molecules: Different mechanisms and specificities can lead to different outcomes. Curr. Opin. Drug Discov. Devel., 2005, 8, 557.
3. Stanisławska, J.; Olszewski, W.L. RNA interference - significance and applications. Arch. Immunol. Ther. Exp. (Warsz), 2005, 53, 39.
4. Kim, V.N. Small RNAs: Classification, biogenesis, and function. Mol. Cells, 2005, 19, 1.
5. Latronico, M.V.; Catalucci, D.; Condorelli, G. Emerging role of microRNAs in cardiovascular biology. Circ. Res., 2007, 101, 1225.
6. Katiyar-Agarwal, S.; Morgan, R.; Dahlbeck, D.; Borsani, O.; Villegas, A., Jr.; Zhu, J.K.; Staskawicz, B.J.; Jin, H. A pathogen-inducible endogenous siRNA in plant immunity. Proc. Natl. Acad. Sci. USA, 2006, 103, 18002.
7. Ruby, J.G.; Jan, C.; Player, C.; Axtell, M.J.; Lee, W.; Nusbaum, C.; Ge, H.; Bartel, D.P. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. Elegans. Cell, 2006, 127, 1193.
8. Sontheimer, E.J.; Carthew, R.W. Silence from within: endogenous siRNAs and miRNAs. Cell, 2005, 122, 9.
9. Pillai, R.S. MicroRNA function: multiple mechanisms for a tiny RNA? RNA, 2005, 11, 1753.
10. Zhang, B.; Wang, Q.; Pan, X. MicroRNAs and their regulatory roles in animals and plants. J. Cell Physiol., 2007, 210, 279.
11. Hannon, G.J.; Rossi, J.J. Unlocking the potential of the human genome with RNA interference. Nature, 2004, 431, 371.
12. Griffiths-Jones, S. The microRNA Registry. Nucleic Acids Res., 2004, 32, D109.
13. Griffiths-Jones, S.; Grocock, R.J.; van Dongen, S.; Bateman, A.; Enright, A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 2006, 34, D140.
14. Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell., 1993, 75, 843.
15. Ambros, V. The functions of animal microRNAs. Nature, 2004, 431, 350.
16. Rodriguez, A.; Griffiths-Jones, S.; Ashurst, J.L.; Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome. Res., 2004, 14, 1902.
17. Li, S.C.; Tang, P.; Lin, W.C. Intronic microRNA: discovery and biological implications. DNA Cell Biol., 2007, 26, 195.
18. Lund, E.; Güttinger, S.; Calado, A.; Dahlberg, J,E.; Kutay, U. Nuclear export of microRNA precursors. Science, 2004, 303, 95.
19. Obernosterer, G.; Leuschner, P.J.; Alenius, M.; Martinez, J. Post-transcriptional regulation of microRNA expression. RNA, 2006, 12, 1161.
20. Kawahara, Y.; Zinshteyn, B.; Sethupathy, P.; Iizasa, H.; Hatzigeorgiou, A.G. Nishikura, K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science, 2007, 315, 1137.
21. Tomari, Y.; Zamore, P.D. Perspective: machines for RNAi. Genes Dev., 2005, 19, 517.
22. Carmell, M.A.; Xuan, Z.; Zhang, M.Q.; Hannon, G.J. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev., 2002, 16, 2733.
23. Liu, J.; Carmell, M.A.; Rivas, F.V.; Marsden, C.G.; Thomson, J.M.; Song, J.J.; Hammond, S.M.; Joshua-Tor, L.; Hannon, G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science, 2004, 305, 1437.
24. Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120, 15.
25. Berezikov, E.; Guryev, V.; van de Belt, J.; Wienholds, E.; Plasterk, R.H.; Cuppen, E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 2005, 120, 21.
26. Lagos-Quintana, M.; Rauhut, R.; Yalcin, A.; Meyer, J.; Lendeckel, W.; Tuschl, T. Identification of tissue-specific microRNAs from mouse. Curr. Biol., 2002, 12, 735.
27. Rao, P.K.; Kumar, R.M.; Farkhondeh, M.; Baskerville, S.; Lodish, H.F. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. USA, 2006, 103, 8721.
28. Zhao, Y.; Ransom, J.F.; Li, A.; Vedantham, V.; von Drehle, M.; Muth, A.N.; Tsuchihashi, T.; McManus, M.T.; Schwartz, R.J.; Srivastava, D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 2007, 129, 303.
29. Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol., 2007, 9, 654.
30. Yekta, S.; Shih, I.H.; Bartel, D.P. MicroRNA-directed cleavage of HOXB8 mRNA. Science, 2004, 304, 594.
31. Meister, G.; Landthaler, M.; Patkaniowska, A.; Dorsett, Y.; Teng, G.; Tuschl, T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell, 2004, 15, 185.
32. Calin, G.A.; Dumitru, C.D.; Shimizu, M.; Bichi, R.; Zupo, S.; Noch, E.; Aldler, H.; Rattan, S.; Keating, M.; Rai, K.; Rassenti, L.; Kipps, T.; Negrini, M.; Bullrich, F.; Croce, C.M. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 2002, 99, 15524.
33. Jing, Q.; Huang, S.; Guth, S.; Zarubin, T.; Motoyama, A.; Chen, J.; Di Padova, F.; Lin, S.C.; Gram, H.; Han, J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell, 2005, 120, 623.
34. Yang, B.; Lin, H.; Xiao, J.; Lu, Y.; Luo, X.; Li, B.; Zhang, Y.; Xu, C.; Bai, Y.; Wang, H.; Chen, G.; Wang, Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med., 2007, 13, 486.
35. Xiao, J.; Luo, X.; Lin, H.; Zhang, Y.; Lu, Y.; Wang, N.; Zhang, Y.; Yang, B.; Wang, Z. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J. Biol. Chem., 2007, 282, 12363.
36. Poliseno, L.; Tuccoli, A.; Mariani, L.; Evangelista, M.; Citti, L.; Woods, K.; Mercatanti, A.; Hammond, S.; Rainaldi, G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood, 2006, 108, 3068.
37. Hua, Z.; Lv, Q.; Ye, W.; Wong, C.K.; Cai, G.; Gu, D.; Ji, Y.; Zhao, C.; Wang, J.; Yang, B.B.; Zhang, Y. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE, 2006, 1, e116.
38. Humphreys, D.T.; Westman, B.J.; Martin, D.I.; Preiss, T. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc. Natl. Acad. Sci. USA, 2005, 102, 16961.
39. Hwang, H.W.; Wentzel, E.A.; Mendell, J.T. A hexanucleotide element directs microRNA nuclear import. Science, 2007, 315, 97.
40. Bentwich, I. Prediction and validation of microRNAs and their targets. FEBS Lett., 2005, 579, 5904.
41. Kim, H.K.; Lee, Y.S.; Sivaprasad, U.; Malhotra, A.; Dutta, A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J. Cell Biol., 2006, 174, 677.
42. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature, 2005, 438, 685.
43. Care, A.; Catalucci, D.; Felicetti, F.; Bonci, D.; Addario, A.; Gallo, P.; Bang, M.L.; Segnalini, P.; Gu, Y.; Dalton, N.D.; Elia, L.; Latronico, M.V.; Hoydal, M.; Autore, C.; Russo, M.A.; Dorn, G.W., 2nd; Ellingsen, O.; Ruiz-Lozano, P.; Peterson, K.L.; Croce, C.M.; Peschle, C.; Condorelli, G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med., 2007, 13, 613.
44. Ebert, M.S.; Neilson, J.R.; Sharp, P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods, 2007, 4, 721.
45. Mann, D.L.; Bristow, M.R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation, 2005, 111, 2837.
46. Zhao, Y.; Samal, E.; Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 2005, 436, 214.
47. Nakajima, N.; Takahashi, T.; Kitamura, R.; Isodono, K.; Asada, S.; Ueyama, T.; Matsubara, H.; Oh, H. MicroRNA-1 facilitates skeletal myogenic differentiation without affecting osteoblastic and adipogenic differentiation. Biochem. Biophys. Res. Commun., 2006, 350, 1006.
48. Mishima, Y.; Stahlhut, C.; Giraldez, A.J. miR-1-2 gets to the heart of the matter. Cell, 2007, 129, 247.
49. Sokol, N.S.; Ambros, V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev., 2005, 19, 2343.
50. Sayed, D.; Hong, C.; Chen, I.Y.; Lypowy, J.; Abdellatif, M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res., 2007, 100, 416.
51. Xu, C.; Lu, Y.; Pan, Z.; Chu, W.; Luo, X.; Lin, H.; Xiao, J.; Shan, H.; Wang, Z.; Yang, B. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J. Cell Sci., 2007, 120, 3045.
52. Chen, J.F.; Mandel, E.M.; Thomson, J.M.; Wu, Q.; Callis, T.E.; Hammond, S.M.; Conlon, F.L.; Wang, D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet., 2006, 38, 228.
53. van Rooij, E.; Sutherland, L.B.; Qi, X.; Richardson, J.A.; Hill, J.; Olson, E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 2007, 316, 575.
54. van Rooij, E.; Sutherland, L.B.; Liu, N.; Williams, A.H.; McAnally, J.; Gerard, R.D.; Richardson, J.A.; Olson, E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA, 2006, 103, 18255.
55. Cheng, Y.; Ji, R.; Yue, J.; Yang, J.; Liu, X.; Chen, H.; Dean, D.B.; Zhang, C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am. J. Pathol., 2007, 170, 1831.
56. Tatsuguchi, M.; Seok, H.Y.; Callis, T.E.; Thomson, J.M.; Chen, J.F.; Newman, M.; Rojas, M.; Hammond, S.M.; Wang, D.Z. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell Cardiol., 2007, 42, 1137.
57. Thum, T. Galuppo, P.; Wolf, C.; Fiedler, J.; Kneitz, S.; van Laake, L.W.; Doevendans, P.A.; Mummery, C.L.; Borlak, J.; Haverich, A.; Gross, C.; Engelhardt, S.; Ertl, G.; Bauersachs, J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation, 2007, 116, 258.
58. Zhu, S.; Si, M.L.; Wu, H.; Mo, Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem., 2007, 282, 14328.
59. Anderson, M.E; Mohler, P. MicroRNA may have macro effect on sudden death. J. Nat. Med., 2007, 13, 410.
60. Anderson, C.; Catoe, H.; Werner, R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res., 2006, 34, 5863.
61. Luo, X.; Xiao, J.; Lin, H.; Li, B.; Lu, Y.; Yang, B.; Wang, Z. J. Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. Cell Physiol., 2007, 212, 358.
62. Xiao, J.; Yang, B.; Lin, H.; Lu, Y.; Luo, X.; Wang, Z. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J. Cell Physiol., 2007, 212, 285.
63. Costantini, D.L.; Arruda, E.P.; Agarwal, P.; Kim, K.H.; Zhu, Y.; Zhu, W.; Lebel, M.; Cheng, C.W.; Park, C.Y.; Pierce, S.A.; Guerchicoff, A.; Pollevick, G.D.; Chan, T.Y.; Kabir, M.G.; Cheng, S.H.; Husain, M.; Antzelevitch, C.; Srivastava, D.; Gross, G.J.; Hui, C.C.; Backx, P.H.; Bruneau, B.G. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell, 2005, 123, 347.
64. Gottlieb, P.D.; Pierce, S.A.; Sims, R.J.; Yamagishi, H.; Weihe, E.K.; Harriss, J.V.; Maika, S.D.; Kuziel, W.A.; King, H.L.; Olson, E.N.; Nakagawa, O.; Srivastava, D. Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat. Genet., 2002, 31, 25.
65. Yang, W.J.; Yang, D.D.; Na, S.; Sandusky, G.E.; Zhang, Q.; Zhao, G. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem., 2005, 280, 9330.
66. Kuehbacher, A.; Urbich, C.; Zeiher, A.M.; Dimmeler, S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res., 2007, 101, 59.
67. Suárez, Y.; Fernández-Hernando, C.; Pober, J.S.; Sessa, W.C. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res., 2007, 100, 1164.
68. Ji, R.; Cheng, Y.; Yue, J.; Yang, J.; Liu, X.; Chen, H.; Dean, D.B.; Zhang, C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res., 2007, 100, 1579.
69. Virmani, R.; Burke, A.P.; Farb, A.; Kark, J.A. Causes of sudden death in young and middle-aged competitive athletes. Cardiol. Clin., 1997, 15, 439.
70. Suárez-Mier, M.P.; Aguilera, B. Causes of sudden death during sports activities in Spain. Rev. Esp. Cardiol., 2002, 55, 347.
71. Tesson, F.; Dufour, C.; Moolman, J.C.; Carrier, L.; al-Mahdawi, S.; Chojnowska, L.; Dubourg, O.; Soubrier, E.; Brink, P.; Komajda, M.; Guicheney, P.; Schwartz, K.; Feingold, J. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J. Mol. Cell Cardiol., 1997, 29, 831.
72. Ortlepp, J.R.; Vosberg, H.P.; Reith, S.; Ohme, F.; Mahon, N.G.; Schröder, D.; Klues, H.G.; Hanrath, P.; McKenna, W.J. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart, 2002, 87, 270.
73. Perkins, M.J.; Van Driest, S.L.; Ellsworth, E.G.; Will, M.L.; Gersh, B.J.; Ommen, S.R.; Ackerman, M.J. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur. Heart J., 2005, 26, 2457.
74. Esau, C.C.; Monia, B.P. Adv. Drug Deliv. Rev., 2007, 59, 101.
75. Britz-Cunningham, S.H.; Shah, M.M.; Zuppan, C.W.; Fletcher, W.H. Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N. Engl. J. Med., 1995, 332, 1323.
76. Krüger, O.; Maxeiner, S.; Kim, J.S.; van Rijen, H.V.; de Bakker, J.M.; Eckardt, D.; Tiemann, K.; Lewalter, T.; Ghanem, A.; Lüderitz, B.; Willecke, K. Cardiac morphogenetic defects and conduction abnormalities in mice homozygously deficient for connexin40 and heterozygously deficient for connexin45. J. Mol. Cell Cardiol., 2006, 41, 787.
77. Kołcz, J.; Drukała, J.; Bzowska, M.; Rajwa, B.; Korohoda, W.; Malec, E. The expression of connexin 43 in children with Tetralogy of Fallot. Cell Mol. Biol. Lett., 2005, 10, 287.
78. Reaume, A.G.; De Sousa, P.A.; Kulkarni, S.; Langille, B.L.; Zhu, D.; Davies, T.C.; Juneja, S.C.; Kidder, G.M.; Rossant, J. Cardiac malformation in neonatal mice lacking connexin43. Science, 1995, 267, 1831.
79. Priori, S.G.; Napolitano, C.; Gasparini, M.; Pappone, C.; Della, B.P.; Brignole, M.; Giordano, U.M; Giovannini, T.; Menozzi, C.; Bloise, R.; Crotti, L.; Terreni, L.; Schwartz, P.J. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation, 2000, 102, 2509.
80. Mack, G.S. MicroRNA gets down to business. Nat. Biotechnol., 2007, 25, 631.